Stocks to watch on Tuesday: CE, IEX, SONC >>> READ MORE


Recent Articles

Thursday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Netflix, Inc. (NFLX) and JPMorgan Chase & Co. (JPM)

Teva (TEVA) options surge on Mylan N.V.’s generic drug approval, Netflix (NFLX) lifted at UBS and JPMorgan Chase (JPM) trades ex-dividend. More 

Mylan N.V. (MYL) Stock Gets Massive Boost From Generic MS Drug Approval

Mylan (MYL) stock was flying high today on approval from the FDA for a generic version of Teva's (TEVA) MS drug Copaxone. More 

Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?

TEVA stock has tanked over the past several months, but is this stock finally cheap enough to compensate for the leveraged risk profile? More 

A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd (TEVA) Stock

Teva Pharmaceuticals has a new CEO, and despite TEVA stock being down more than 53% this year, now may be a time to buy. More 

Go Long Teva Pharmaceuticals Industries Ltd (ADR) (TEVA) Stock With Less Speculation

Conditions are looking up for TEVA stock both off and on the price chart, but position more smartly with this play. More 

Tuesday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Snap Inc (SNAP) and Tesla Inc (TSLA)

Teva (TEVA) call options surge on new CEO, Snap (SNAP) panned at Deutsche Bank and Tesla (TSLA) announces layoffs at SolarCity. More 

Post-Hurricane Enthusiasm Keeps Pushing S&P 500 Higher

But can the S&P 500 keep riding higher, or are the markets due for a bounce in the near term? More